Skip to main content

Table 5 Characteristics of the validation cohort of ECMO patients (n = 5)

From: Vancomycin population pharmacokinetics during extracorporeal membrane oxygenation therapy: a matched cohort study

Patient

Weight, kg

LD, mg

DD, mg

CrCl, mL/minute

CRRT

CRRT Intensity, ml/kg

ECMO

1

71

2485

1750

260

N

NA

VV

2

70

2450

1000

53

Y

21

VV

3

80

2800

1250

11

Y

31

VV

4

70

2450

1050

17

Y

21

VV

5

80

2800

3500

267

N

NA

VA

  1. Age (range 45 to 71 years) and gender (4 male/1 female) were not reported to protect the anonymity of the patients. LD, loading dose; DD, daily dose; CrCl, creatinine Clearance; CRRT, continuous renal replacement therapy; VA ECMO, veno-arterial extracorporeal membrane oxygenation; VV ECMO, veno-venous extracorporeal membrane oxygenation; Y, yes; N, no.
Back to article page

Critical Care

ISSN: 1364-8535